Clinical Trial Update: A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating venetoclax in combination with azacitidine in treatment-naïve, higher-risk myelodysplastic syndromes is ongoing. The study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• VIDAZA (AZACITIDINE)
• Venclexta (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Myelodysplastic Syndromes (MDS) | Phase 1 | Status: ACTIVE_NOT_RECRUITING